Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster
- 7 June 2010
- Vol. 28 (25) , 4204-4209
- https://doi.org/10.1016/j.vaccine.2010.04.003
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of ZostavaxClinical and Vaccine Immunology, 2008
- Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and OlderJournal of the American Geriatrics Society, 2007
- The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detectionJournal of Medical Virology, 2006
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Agreement Between Patient Reports of Cardiovascular Disease and Patient Medical RecordsMayo Clinic Proceedings, 2005
- Herpes ZosterNew England Journal of Medicine, 2002
- Equivalence test and confidence interval for the difference in proportions for the paired-sample designStatistics in Medicine, 1998